Respiratory Syncytial Virus and Palivizumab: Where are We in 2014?
Saved in:
Main Author: | Joan Robinson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2014/158919 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Respiratory Syncytial Virus Pneumonia Treated with Lower-Dose Palivizumab in a Heart Transplant Recipient
by: J. L. Grodin, et al.
Published: (2012-01-01) -
The Real-Life Effectiveness of Palivizumab for Reducing Hospital Admissions for Respiratory Syncytial Virus in Infants Residing in Nunavut
by: Anna Banerji, et al.
Published: (2014-01-01) -
Recommendation for the use of respiratory syncytial virus vaccines
by: Ping-Ing Lee, et al.
Published: (2025-02-01) -
Burden of Respiratory Syncytial Virus Hospitalizations in Canada
by: Ian Mitchell, et al.
Published: (2017-01-01) -
Paroxysmal Cold Hemoglobinuria in an Adult with Respiratory Syncytial Virus
by: Ryan Leibrandt, et al.
Published: (2018-01-01)